Skip to main content
Top
Published in: Diabetology & Metabolic Syndrome 1/2017

Open Access 01-12-2017 | Research

Understanding the barriers and improving care in type 2 diabetes: Brazilian perspective in time to do more in diabetes

Authors: Sérgio Vencio, Päivi M. Paldánius, Matthias Blüher, Daniel Giannella-Neto, Rafael Caiado-Vencio, W. David Strain

Published in: Diabetology & Metabolic Syndrome | Issue 1/2017

Login to get access

Abstract

Background

Type 2 diabetes mellitus (T2DM) is a complex disease, particularly in a continental country like Brazil. We attempted to understand and evaluate the perceptions and routines of Brazilians with T2DM and physicians, compared with other countries.

Methods

We compared the results from a 20-min online survey in Brazil with simultaneously collated data from India, Japan, Spain, UK and USA.

Results

In total, 652 adults with T2DM and 337 treating physicians were enrolled, of whom 100 patients and 55 physicians were from Brazil. The numbers of primary care physicians from the five countries were 221 versus 43 in Brazil, diabetes specialists were 61 versus 12. There was disconnect between the opinions of physicians and people with diabetes globally. Further, there were differences between clinical practices in Brazil versus the rest of the world, in many areas Brazilians were performing better.

Conclusions

Communication between patients and physicians should be clearer. There is an urgent need to identify the deficits in education, in order to address the clinical inertia within the diabetes management team. There is a necessity to understand the specific requirements of the Brazilian population in order to contextualise international guidelines and implement local changes in practice.
Literature
2.
go back to reference Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, Hadden D, Turner RC, Holman RR. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000;321:405–12.CrossRefPubMedPubMedCentral Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, Hadden D, Turner RC, Holman RR. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000;321:405–12.CrossRefPubMedPubMedCentral
3.
go back to reference Del Prato S. Megatrials in type 2 diabetes. From excitement to frustration? Diabetologia. 2009;52:1219–26.CrossRefPubMed Del Prato S. Megatrials in type 2 diabetes. From excitement to frustration? Diabetologia. 2009;52:1219–26.CrossRefPubMed
4.
go back to reference Strain WD, Blüher M, Paldánius P. Clinical inertia in individualising care for diabetes: is there time to do more in type 2 diabetes? Diabetes Ther. 2014;5:347–54.CrossRefPubMedPubMedCentral Strain WD, Blüher M, Paldánius P. Clinical inertia in individualising care for diabetes: is there time to do more in type 2 diabetes? Diabetes Ther. 2014;5:347–54.CrossRefPubMedPubMedCentral
5.
go back to reference Casagrande S, Fradkin J, Saydah S, Rust K, Cowie C. The prevalence of meeting A1C, blood pressure, and LDL goals among people with diabetes, 1988–2010. Diabetes Care. 2013;36:2271–9.CrossRef Casagrande S, Fradkin J, Saydah S, Rust K, Cowie C. The prevalence of meeting A1C, blood pressure, and LDL goals among people with diabetes, 1988–2010. Diabetes Care. 2013;36:2271–9.CrossRef
6.
go back to reference Paul SK, Klein K, Thorsted BL, Wolden ML, Khunti K. Delay in treatment intensification increases the risks of cardiovascular events in patients with type 2 diabetes. Cardiovasc Diabetol. 2015;14:100.CrossRefPubMedPubMedCentral Paul SK, Klein K, Thorsted BL, Wolden ML, Khunti K. Delay in treatment intensification increases the risks of cardiovascular events in patients with type 2 diabetes. Cardiovasc Diabetol. 2015;14:100.CrossRefPubMedPubMedCentral
7.
go back to reference Huang LY, Shau WY, Yeh HL, Chen TT, Hsieh JY, Su S, Lai MS. A model measuring therapeutic inertia and the associated factors among diabetes patients: a nationwide population-based study in Taiwan. J Clin Pharmacol. 2015;55:17–24.CrossRefPubMed Huang LY, Shau WY, Yeh HL, Chen TT, Hsieh JY, Su S, Lai MS. A model measuring therapeutic inertia and the associated factors among diabetes patients: a nationwide population-based study in Taiwan. J Clin Pharmacol. 2015;55:17–24.CrossRefPubMed
8.
go back to reference Khunti S, Davies MJ, Khunti K. Clinical inertia in the management of type 2 diabetes mellitus: a focused literature review. Br J Diabetes Vasc Dis. 2015;15:65–9.CrossRef Khunti S, Davies MJ, Khunti K. Clinical inertia in the management of type 2 diabetes mellitus: a focused literature review. Br J Diabetes Vasc Dis. 2015;15:65–9.CrossRef
9.
go back to reference Zafar A, Stone MA, Davies MJ, Khunti K. Acknowledging and allocating responsibility for clinical inertia in the management of Type 2 diabetes in primary care: a qualitative study. Diabet Med. 2015;32:407–13.CrossRefPubMed Zafar A, Stone MA, Davies MJ, Khunti K. Acknowledging and allocating responsibility for clinical inertia in the management of Type 2 diabetes in primary care: a qualitative study. Diabet Med. 2015;32:407–13.CrossRefPubMed
10.
go back to reference Strain WD, Cos X, Hirst M, Vencio S, Mohan V, Vokó Z, Yabe D, Blüher M, Paldánius PM. Time to do more: addressing clinical inertia in the management of type 2 diabetes mellitus. Diabetes Res Clin Pract. 2014;105:302–12.CrossRefPubMed Strain WD, Cos X, Hirst M, Vencio S, Mohan V, Vokó Z, Yabe D, Blüher M, Paldánius PM. Time to do more: addressing clinical inertia in the management of type 2 diabetes mellitus. Diabetes Res Clin Pract. 2014;105:302–12.CrossRefPubMed
11.
go back to reference de Almeida-Pititto B, Dias ML, de Moraes AC, Ferreira SR, Franco DR, Eliaschewitz FG. Type 2 diabetes in Brazil: epidemiology and management. Diabetes Metab Syndr Obes. 2015;8:17–28.PubMedPubMedCentral de Almeida-Pititto B, Dias ML, de Moraes AC, Ferreira SR, Franco DR, Eliaschewitz FG. Type 2 diabetes in Brazil: epidemiology and management. Diabetes Metab Syndr Obes. 2015;8:17–28.PubMedPubMedCentral
12.
go back to reference Lerario AC, Chacra AR, Pimazoni-Netto A, Malerbi D, Gross JL, Oliveira JE, Gomes MB, Santos RD, Fonseca RM, Betti R, Raduan R. Algorithm for the treatment of type 2 diabetes: a position statement of Brazilian Diabetes Society. Diabetol Metab Syndr. 2010;2:35.CrossRefPubMedPubMedCentral Lerario AC, Chacra AR, Pimazoni-Netto A, Malerbi D, Gross JL, Oliveira JE, Gomes MB, Santos RD, Fonseca RM, Betti R, Raduan R. Algorithm for the treatment of type 2 diabetes: a position statement of Brazilian Diabetes Society. Diabetol Metab Syndr. 2010;2:35.CrossRefPubMedPubMedCentral
13.
go back to reference Del Prato S, Foley JE, Kothny W, Kozlovski P, Stumvoll M, Paldánius PM, Matthews DR. Study to determine the durability of glycaemic control with early treatment with a vildagliptin–metformin combination regimen vs. standard-of-care metformin monotherapy—the VERIFY trial: a randomized double-blind trial. Diabet Med. 2014;31:1178–84.CrossRefPubMedPubMedCentral Del Prato S, Foley JE, Kothny W, Kozlovski P, Stumvoll M, Paldánius PM, Matthews DR. Study to determine the durability of glycaemic control with early treatment with a vildagliptin–metformin combination regimen vs. standard-of-care metformin monotherapy—the VERIFY trial: a randomized double-blind trial. Diabet Med. 2014;31:1178–84.CrossRefPubMedPubMedCentral
14.
go back to reference ACCORD Study Group. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008;358:2545–59.CrossRef ACCORD Study Group. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008;358:2545–59.CrossRef
15.
go back to reference Look AHEAD Research Group. Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med. 2013;369:145–54.CrossRef Look AHEAD Research Group. Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med. 2013;369:145–54.CrossRef
16.
go back to reference ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008;358:2560–72.CrossRef ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008;358:2560–72.CrossRef
17.
go back to reference UKPDS Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998;352:837–53.CrossRef UKPDS Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998;352:837–53.CrossRef
18.
go back to reference Parisi MC, Neto MA, Menezes FH, Gomes MB, Teixeira RM, de Oliveira JE, Pereira JR, Fonseca RM, Guedes LB, E Forti CA, de Oliveira AM, de Nóbrega MMB, Colares VN, Schmid H, Nienov OH, Nery M, Fernandes TD, Pedrosa HC, Schreiber de Oliveira Cda S, Ronsoni M, Rezende KF, Quilici MT, Vieira AE, de Macedo GM, Stuchi-Perez EG, Dinhane KG, Pace AE, de Freitas MC, Calsolari MR, Saad MJ. Baseline characteristics and risk factors for ulcer, amputation and severe neuropathy in diabetic foot at risk: the BRAZUPA study. Diabetol Metab Syndr. 2016;8:25.CrossRefPubMedPubMedCentral Parisi MC, Neto MA, Menezes FH, Gomes MB, Teixeira RM, de Oliveira JE, Pereira JR, Fonseca RM, Guedes LB, E Forti CA, de Oliveira AM, de Nóbrega MMB, Colares VN, Schmid H, Nienov OH, Nery M, Fernandes TD, Pedrosa HC, Schreiber de Oliveira Cda S, Ronsoni M, Rezende KF, Quilici MT, Vieira AE, de Macedo GM, Stuchi-Perez EG, Dinhane KG, Pace AE, de Freitas MC, Calsolari MR, Saad MJ. Baseline characteristics and risk factors for ulcer, amputation and severe neuropathy in diabetic foot at risk: the BRAZUPA study. Diabetol Metab Syndr. 2016;8:25.CrossRefPubMedPubMedCentral
19.
go back to reference Boyko EJ, Ahroni JH, Cohen V, Nelson KM, Heagerty PJ. Prediction of diabetic foot ulcer occurrence using commonly available clinical information: the Seattle Diabetic Foot Study. Diabetes Care. 2006;6:1202–7.CrossRef Boyko EJ, Ahroni JH, Cohen V, Nelson KM, Heagerty PJ. Prediction of diabetic foot ulcer occurrence using commonly available clinical information: the Seattle Diabetic Foot Study. Diabetes Care. 2006;6:1202–7.CrossRef
20.
go back to reference Prompers L, Huijberts M, Alpeqvist J, Jude E, Piaggesi A, Bakker K, Edmonds M, Holstein P, Jirkovska A, Mauricio D, Tennvall GR, Reike H, Spraul M, Uccioli L, Urbancic V, Van Acker K, Van Baal J, Van Merode F, Schaper N. Delivery of care to diabetic patients with foot ulcers in daily practice: results of the Eurodiale study, a prospective cohort study. Diabet Med. 2008;25:700–7.CrossRefPubMed Prompers L, Huijberts M, Alpeqvist J, Jude E, Piaggesi A, Bakker K, Edmonds M, Holstein P, Jirkovska A, Mauricio D, Tennvall GR, Reike H, Spraul M, Uccioli L, Urbancic V, Van Acker K, Van Baal J, Van Merode F, Schaper N. Delivery of care to diabetic patients with foot ulcers in daily practice: results of the Eurodiale study, a prospective cohort study. Diabet Med. 2008;25:700–7.CrossRefPubMed
21.
go back to reference Severo MD, Leiria LF, Ledur Pdos S, Becker AD, Aguiar FM, Massierer D, Gus M, Schaan BD. Association between erectile dysfunction and echocardiographic variables of ventricular hypertrophy and diastolic function in hypertensive patients with type 2 diabetes mellitus: a cross-sectional study. J Diabetes. 2014;6:586–9.CrossRefPubMed Severo MD, Leiria LF, Ledur Pdos S, Becker AD, Aguiar FM, Massierer D, Gus M, Schaan BD. Association between erectile dysfunction and echocardiographic variables of ventricular hypertrophy and diastolic function in hypertensive patients with type 2 diabetes mellitus: a cross-sectional study. J Diabetes. 2014;6:586–9.CrossRefPubMed
Metadata
Title
Understanding the barriers and improving care in type 2 diabetes: Brazilian perspective in time to do more in diabetes
Authors
Sérgio Vencio
Päivi M. Paldánius
Matthias Blüher
Daniel Giannella-Neto
Rafael Caiado-Vencio
W. David Strain
Publication date
01-12-2017
Publisher
BioMed Central
Published in
Diabetology & Metabolic Syndrome / Issue 1/2017
Electronic ISSN: 1758-5996
DOI
https://doi.org/10.1186/s13098-017-0244-y

Other articles of this Issue 1/2017

Diabetology & Metabolic Syndrome 1/2017 Go to the issue